Effect of interferon-α on multi-drug resistance in gastric cancer multi-drug resistance cell lines

Jian LI,Ning LI,Ke-jin WU,Zhe-wei FEI,Jing-min OU,Min YE

DOI: https://doi.org/10.3969/j.issn.1006-5725.2008.12.012

2008-01-01

Abstract:Objective To investigate the effect of interferon-α on multi-drug resistance in gastric cancer multi-drug resistance cell lines. Methods SGC7901/VCR gastric cancer multi-drug resistance cell lines were treated with interferon-α at different concentrations(0,103,104,105 U/mL), these treatments were terminated at indicated time points, then the cells were collected respectively. The relative change of mRNA expression of MDR1 was detected using RT-PCR, the protein expression of MDR1 was detected using flow cytometry. MTT assay was used to detect the changes of drug resistance spectrum with or without treatment with interferon-α at 105 U/mL concentration for 48 hours. Results The relative expression of MDR1 in mRNA and protein level was decreased as the concentration of interferon-α increased and treatment time was prolonged. The mRNA and protein expression of MDR1 was decreased significantly after treatment with interferon-α at 105 U/mL of concentration for 48 hours. MTT assay showed that the drug resistance of SGC7901/VCR cells to chemotherapeutants was reversed at different levels. Vincristine was most sensitive to the treatment with interferon-α, the others were hydroxycamptothecin and 5-fluorouracil respectively. Treatment with interferon-α did not markedly influence the chemotherapeutic effect of mitomycin and carboplatin. Conclusions Treatment with interferon-α can partly reverse the multi-drug resistance in SGC7901/VCR gastric cancer multi-drug resistance cell lines,and the effect is dependent on different chemotherapeutants. The inhibition of interferon-α on the mRNA expression and protein synthesis of MDR1 may be one of the possible mechanisms by which interferon-α decreases the pumping effect of MDR1 protein to chemotherapeutants.